- Home
- BBAR vs NVCR Comparison
BBAR vs NVCR Comparison
Compare BBAR & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBAR | NVCR |
|---|---|---|
| Founded | 1886 | 2000 |
| Country | Argentina | Switzerland |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BBAR | NVCR |
|---|---|---|
| Price | $18.54 | $12.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $22.00 | ★ $28.42 |
| AVG Volume (30 Days) | 763.1K | ★ 1.8M |
| Earning Date | 11-25-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.86% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $1,535,146,865.00 | $642,269,000.00 |
| Revenue This Year | N/A | $9.75 |
| Revenue Next Year | $19.02 | $5.62 |
| P/E Ratio | $28.57 | ★ N/A |
| Revenue Growth | N/A | ★ 11.17 |
| 52 Week Low | $7.76 | $10.70 |
| 52 Week High | $25.01 | $34.13 |
Technical Indicators
Market Signals| Indicator | BBAR | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 71.98 | 52.10 |
| Support Level | $16.21 | $12.30 |
| Resistance Level | $17.37 | $13.94 |
| Average True Range (ATR) | 0.89 | 0.66 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 95.68 | 59.37 |
Price Performance
Historical ComparisonAbout BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.